Tom began his working life in financial services in New York, specialising in European and Latin American debt. In 1983 he entered politics, and served for 14 years as Conservative MP for the Lancashire constituency of Bolton West.
During this period he founded the All Party Committee on Drug Misuse, and served as Parliamentary Private Secretary to the ministers in the Department of Health and Social Security and the Northern Ireland Office.
He was later appointed Government Whip, and served as a minister at the Department of Health and subsequently at the Home Office. Since 1998 Tom has been Chief Executive of the International Federation of Health Plans, the leading global network of the health insurance industry. He is founder and chairman of a family support charity, and advisor to an NHS Treatment Centre and a leading healthcare IT provider.
Stefano started his career with his family’s group of companies, which includes private clinics and diagnostic equipment manufacturing in Italy, France and the United States.
He joined Arthur Andersen in London in 1996, where he was a member of the healthcare corporate finance team. In 1999, Stefano founded NephroNet, a chain of independent dialysis centers in Italy, which was sold to Baxter in 2001. From 2001 to 2003 Stefano was a Managing Director of Baxter Renal Therapy Services. Since 2002 Stefano is a partner at Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures that he founded. As part of his investment activities Stefano is a shareholder and board member of several healthcare ventures and private equity funds.
Stefano earned an MBA from the Imperial College Management School in 1994.
Scott started his career in banking with Merrill Lynch in New York in 1987. Formerly Scott was a senior manager in global corporate development at National Medical Care (NMC), at the time the world’s largest Haemdialysis provider. During his tenure at NMC he assisted in building the international division and completed over 100 haemodialysis clinic transactions.
He played a key role in building NMCs leading UK and European presence. Since 2002 Scott has been a partner at Healthcare Capital Partners, a company that he founded with Stefano Ciampolini. He is also CEO of Lipoxen Plc, a biotechnology company he listed on AIM (ticker symbol LPX) in 2006. Prior to HCP Scott was director (1996-2001) of Arthur Andersen’s Healthcare Corporate Finance, a practice he co-founded in 1996. While at Andersen, Scott advised a number of leading dialysis companies including Althin Medical (manufacturer of dialysis products and consumables) on the sale to Baxter (1999) and Total Renal Care (now DaVita) on their European business development initiatives (1997-1999).
Scott earned an MBA from the Babson Graduate School in 1993.
Graduated with a PhD in electrical engineering and MS in finance, investment and banking from the University of Wisconsin-Madison in 1998.
After graduation he worked for Prudential Securities Inc. in New York where he was responsible for structuring asset-backed securities, and subsequently for Tufton Oceanic in Cyprus and Dubai where he was responsible for developing fund management products and working on corporate finance transactions in the maritime sector.
He joined the Interorient Group, Cyprus, in 2005 where he is responsible for business development. He has been actively involved in several acquisitions and joint venture investments and has served on the boards of public and private companies.
Graduated from Delta State University, Mississippi, and Linkoping University in Sweden with BBAs in Finance, Accounting and Management Control. He joined Evli Bank in Stockholm following their acquisition of Arthur Andersen’s Nordic Corporate Finance operations.
Since then he has been responsible for Evli’s Healthcare Corporate Finance team. Since August 2008, Henrik had been head of their Swedish corporate finance operation.
Prior to joining Evli, Henrik worked at Arthur Andersen for many years mainly in Corporate Finance at their London and Stockholm offices. Henrik has project led a significant number of domestic and cross-border transactions in various industries.
Dr Carr graduated in medicine from King’s College London in 1981 and has been a consultant nephrologist since 1993. He is a Specialty Advisor to the Royal College of Physicians in London responsible for College approval of all consultants.
Dr Carr Chairs the Specialist Training Committee for the South Thames Region and is responsible for all postgraduate training in Nephrology. He is Senior Renal Physician and Clinical Lead Board Member at Worthing & Southlands NHS Trust and Consultant Nephrologist to Brighton Healthcare Trust.
Over the past 20 years Dr Carr has held a number of managerial and clinical positions inside the NHS and published several articles in European medical journals.
Kathy has worked as a renal nurse specialist since 1994 and has been involved in the development and management of dialysis centres in the UK since 1998. She has managed renal services for Total Renal Care, Fresenius Medical Care and The London Clinic. As HR Project Manager at The London Clinic Kathy was a key specialist in the delivery of the Human Resources strategy in enabling the organisation to become the employer of choice and in securing cost savings of over £1.5m in the first year of the project.
Kathy is responsible for the delivery and management of all clinical services provided by Renal Services incorporating human resources management and business development. She provides nursing leadership to ensure the highest level of professional practice and patient care is met.
In addition to being a qualified RN Kathy has an MBA, BSc Honours Degree in Health Services Management and she is PRINCE 2 qualified.
Formerly Daniel was a Management Accountant for Savills plc where he worked for their fund management arm, Cordea Savills specialising in global property portfolios.
Prior to that he worked as an Accountant for the UK leading commercial energy supplier, Corona Energy Ltd (part of Macquarie Bank).
Daniel is a qualified chartered accountant and an associate member of CIMA. He is also a BEng (2004) engineering graduate from the University of Leicester.
Neluka has 12 years experience in renal nursing in both public and private sector hospitals. In her last position at the London Clinic she was responsible for developing, implementing and maintaining the nursing module of the patient information system. Her academic background is in chemistry and has a PhD in Organic Chemistry.
Neluka is responsible for the co-ordination and development of clinical governance activities and for the Renal Services’ registration programme with the Care Quality Commission. She is also responsible for monitoring standards of care in all the renal units and leads on all tendering for new business.
